Post by icemandios on Jan 26, 2021 13:59:19 GMT
OraSure’s OMNIgene®·ORAL Saliva Collection Kit Selected by Chronomics for Use in UK Government “Test to Release for International Travel” COVID-19 Testing Program
BETHLEHEM, Pa., Jan. 26, 2021 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-care diagnostic tests, specimen collection devices, and microbiome laboratory and analytical services, today announced that Chronomics Limited has selected the OMNIgene®·ORAL (OME-505) saliva collection device as a component of its SARS CoV-2 PCR test. Chronomics Limited will supply its test for the United Kingdom’s “Test to Release for International Travel” program. The OMNIgene®·ORAL device is a product of OraSure’s DNA Genotek subsidiary.
The “Test to Release for International Travel” program enables travelers to England to purchase a COVID-19 test privately from providers including Chronomics. Travelers who receive a negative test result can reduce their self-isolation period. The project is part of the UK’s plan to use Covid-19 testing to reduce the spread of the virus.
“Our selection as a supplier of oral fluid sample collection devices by Chronomics demonstrates the broad applicability of DNA Genotek’s technology and capabilities in testing for, and helping to reduce the spread of, COVID-19 and confirms DNA Genotek’s position as the leading provider of saliva-based collection kits for detection of SARS CoV-2,” said Kathleen Weber, Executive Vice President, Business Unit Leader, Molecular Solutions at DNA Genotek. “If we want people to widely adopt COVID-19 testing, a requirement to manage the current pandemic and slowly get back to normal life, we need to make the process painless, cost-effective, scalable and simple.”
“Our COVID-19 PCR laboratory test, using DNA Genotek’s OMNIgene®·ORAL as the saliva collection device, is non-invasive, easy to self-administer and the gold standard in COVID-19 tests. We all have a responsibility to minimize the spread of Covid-19 and our saliva test makes it far simpler to provide customers with an easy and accurate way to test for the virus,” said Dr. Tom Stubbs, CEO of Chronomics.
DNA Genotek’s saliva collection devices are widely used in molecular testing to detect active COVID-19 infection. The OMNIgene®·ORAL (OME-505) collection device has Emergency Use Authorization (EUA) from the United States Food and Drug Administration (FDA) and is CE marked for use in the European Union. DNA Genotek’s sample collection devices have been included in seven customer EUAs from a range of laboratories facilitating non-invasive collection of saliva samples for COVID-19 tests.
About OraSure Technologies
OraSure Technologies empowers the global community to improve health and wellness by providing access to accurate, essential information. OraSure, together with its wholly-owned subsidiaries, DNA Genotek, Diversigen, and Novosanis, provides its customers with end-to-end solutions that encompass tools, services and diagnostics. The OraSure family of companies is a leader in the development, manufacture, and distribution of rapid diagnostic tests, sample collection and stabilization devices, and molecular services solutions designed to discover and detect critical medical conditions. OraSure’s portfolio of products is sold globally to clinical laboratories, hospitals, physician’s offices, clinics, public health and community-based organizations, research institutions, government agencies, pharma, commercial entities and direct to consumers. For more information about OraSure, visit www.orasure.com
About DNA Genotek
DNA Genotek Inc., a subsidiary of OraSure Technologies, Inc., focuses on providing high-quality biological sample collection products and end-to-end services for human genomics and microbiome applications. The Company's Oragene®·Dx and ORAcollect®·Dx product lines are the first and only FDA 510(k) cleared saliva-based DNA collection devices for in vitro diagnostic use. DNA Genotek also offers Research Use Only products to collect and preserve large amounts of DNA or RNA from multiple sample types. DNA Genotek markets its products worldwide and has a global customer base with thousands of customers in over 100 countries. For more information about DNA Genotek, visit www.dnagenotek.com
About Chronomics
Founded in 2017, Chronomics, Ltd. is a UK-based biotechnology company founded on the use of epigenetics to give people the knowledge of how their environment and lifestyle is imprinting itself on their DNA and affecting their health. In response to the COVID-19 pandemic, Chronomics developed a CE-marked, UK Government-approved saliva testing kit trusted by thousands of people per day across Europe to detect the presence of RNA from SARS-CoV-2 (COVID-19 virus). visit www.chronomics.com or contact at [email protected]
BETHLEHEM, Pa., Jan. 26, 2021 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-care diagnostic tests, specimen collection devices, and microbiome laboratory and analytical services, today announced that Chronomics Limited has selected the OMNIgene®·ORAL (OME-505) saliva collection device as a component of its SARS CoV-2 PCR test. Chronomics Limited will supply its test for the United Kingdom’s “Test to Release for International Travel” program. The OMNIgene®·ORAL device is a product of OraSure’s DNA Genotek subsidiary.
The “Test to Release for International Travel” program enables travelers to England to purchase a COVID-19 test privately from providers including Chronomics. Travelers who receive a negative test result can reduce their self-isolation period. The project is part of the UK’s plan to use Covid-19 testing to reduce the spread of the virus.
“Our selection as a supplier of oral fluid sample collection devices by Chronomics demonstrates the broad applicability of DNA Genotek’s technology and capabilities in testing for, and helping to reduce the spread of, COVID-19 and confirms DNA Genotek’s position as the leading provider of saliva-based collection kits for detection of SARS CoV-2,” said Kathleen Weber, Executive Vice President, Business Unit Leader, Molecular Solutions at DNA Genotek. “If we want people to widely adopt COVID-19 testing, a requirement to manage the current pandemic and slowly get back to normal life, we need to make the process painless, cost-effective, scalable and simple.”
“Our COVID-19 PCR laboratory test, using DNA Genotek’s OMNIgene®·ORAL as the saliva collection device, is non-invasive, easy to self-administer and the gold standard in COVID-19 tests. We all have a responsibility to minimize the spread of Covid-19 and our saliva test makes it far simpler to provide customers with an easy and accurate way to test for the virus,” said Dr. Tom Stubbs, CEO of Chronomics.
DNA Genotek’s saliva collection devices are widely used in molecular testing to detect active COVID-19 infection. The OMNIgene®·ORAL (OME-505) collection device has Emergency Use Authorization (EUA) from the United States Food and Drug Administration (FDA) and is CE marked for use in the European Union. DNA Genotek’s sample collection devices have been included in seven customer EUAs from a range of laboratories facilitating non-invasive collection of saliva samples for COVID-19 tests.
About OraSure Technologies
OraSure Technologies empowers the global community to improve health and wellness by providing access to accurate, essential information. OraSure, together with its wholly-owned subsidiaries, DNA Genotek, Diversigen, and Novosanis, provides its customers with end-to-end solutions that encompass tools, services and diagnostics. The OraSure family of companies is a leader in the development, manufacture, and distribution of rapid diagnostic tests, sample collection and stabilization devices, and molecular services solutions designed to discover and detect critical medical conditions. OraSure’s portfolio of products is sold globally to clinical laboratories, hospitals, physician’s offices, clinics, public health and community-based organizations, research institutions, government agencies, pharma, commercial entities and direct to consumers. For more information about OraSure, visit www.orasure.com
About DNA Genotek
DNA Genotek Inc., a subsidiary of OraSure Technologies, Inc., focuses on providing high-quality biological sample collection products and end-to-end services for human genomics and microbiome applications. The Company's Oragene®·Dx and ORAcollect®·Dx product lines are the first and only FDA 510(k) cleared saliva-based DNA collection devices for in vitro diagnostic use. DNA Genotek also offers Research Use Only products to collect and preserve large amounts of DNA or RNA from multiple sample types. DNA Genotek markets its products worldwide and has a global customer base with thousands of customers in over 100 countries. For more information about DNA Genotek, visit www.dnagenotek.com
About Chronomics
Founded in 2017, Chronomics, Ltd. is a UK-based biotechnology company founded on the use of epigenetics to give people the knowledge of how their environment and lifestyle is imprinting itself on their DNA and affecting their health. In response to the COVID-19 pandemic, Chronomics developed a CE-marked, UK Government-approved saliva testing kit trusted by thousands of people per day across Europe to detect the presence of RNA from SARS-CoV-2 (COVID-19 virus). visit www.chronomics.com or contact at [email protected]